This guide can help you prepare for a clinical conversation. It does not diagnose a condition or replace individualized medical care.
What is menopause hormone therapy?
Menopause hormone therapy—also called menopausal hormone therapy or HRT—uses estrogen, with a progestogen when needed, to treat selected menopause symptoms. The right treatment depends on what symptom is being treated, whether the uterus is present, medical history, route preference, and individual risk factors.
What symptoms can HRT treat?
Systemic estrogen therapy is an effective treatment for bothersome hot flashes and night sweats. Estrogen can also help vaginal dryness and related genitourinary symptoms, although local vaginal therapy may be preferred when those are the only symptoms. Systemic estrogen can also help prevent bone loss in selected patients.
Symptoms such as fatigue, poor sleep, mood changes, brain fog, and weight changes may occur during the menopause transition, but they are not always caused by estrogen deficiency alone. Treatment should not assume one explanation for every symptom.
What is the difference between systemic and local estrogen?
Systemic estrogen reaches the bloodstream and can be delivered through pills, patches, gels, or sprays. It is used when symptoms such as hot flashes or night sweats require systemic treatment.
Local vaginal estrogen delivers a lower dose to vaginal tissues and is often used when vaginal dryness, painful sex, or related urinary symptoms are the main concerns.
When is progesterone needed?
If a patient still has a uterus and uses systemic estrogen, a progestogen is generally needed to protect the endometrium. Patients who have had a hysterectomy may have different options.
Read estrogen vs estrogen + progesterone for a patient-friendly explanation.
What are the main safety considerations?
Hormone therapy is not appropriate for everyone. Medical history matters, including breast or endometrial cancer, blood clots, stroke, heart attack, liver disease, unexplained vaginal bleeding, pregnancy possibility, blood pressure, and other cardiovascular risks.
The route, dose, and formulation also matter. See HRT benefits and risks and who may be a candidate for HRT.
What about compounded “bioidentical” hormones?
Some FDA-approved estradiol and micronized progesterone products are chemically identical to hormones made by the body. A product does not need to be compounded to be “bioidentical.” When an approved product can meet the patient’s needs, FDA-approved therapy is generally preferred over custom-compounded preparations.
How is HRT monitored?
Follow-up focuses on whether target symptoms improve, whether side effects or bleeding occur, and whether the treatment still fits the patient’s health history and goals. Routine hormone “optimization” testing is not the main way most menopause therapy is managed.
Read HRT monitoring and follow-up or explore Mindfuse Health’s online HRT program.
Sources & clinical references
- Hormone Therapy for Menopause American College of Obstetricians and Gynecologists
- The Menopause Years American College of Obstetricians and Gynecologists
- Menopause U.S. Food and Drug Administration
